"As an existing Merge Cardio™ and Hemo™ client, Tampa General Hospital was excited to expand their partnership with Merge. Tampa General Hospital expressed specific needs in looking for a CTMS system to consolidate and streamline their clinical trial management and research operations throughout the organization," said Justin Dearborn, President of Merge Healthcare. "We're pleased that Merge CTMS provides the opportunity to meet these needs using a highly intuitive interface for a wide variety of users who will access the application on a daily basis."
Through enhanced productivity and business management tools, Merge CTMS for Investigators allows research organizations to centralize study information, organize research activities, and improve recruitment and financial performance. Merge CTMS scales easily from one to many sites, offering a comprehensive suite of CTMS tools for independent research sites, physician networks, SMOs, hospitals, health systems and academic medical centers.
About Merge Healthcare
Merge is a leading provider of clinical systems and innovations that seek to transform healthcare. Merge's enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 20 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit
The Merge Healthcare logo is available at
About Tampa General Hospital
Tampa General is a private not-for-profit hospital and one of the most comprehensive medical facilities in West Central Florida serving a dozen counties with a population in excess of 4 million. As one of the largest hospitals in Florida, Tampa General is licensed for 1,018 beds, and with approximately 6,600 employees, is one of the region's largest employers. For more information, visit
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words "will," "believes," "intends," "anticipates," "expects" and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.
CONTACT: Media Contacts:
Vice President, Marketing